Arsenic Toxicity
Assessment and Posttest
Course: WB 1576
CE Original Date: October 1, 2009
CE Renewal Date: October 1, 2011
CE Expiration Date: October 1, 2013
en Español
Download Printer-Friendly version [PDF - 1.43 MB]
Previous Section | Next Section |
Introduction |
ATSDR seeks feedback on this course so we can asses its usefulness and effectiveness. We ask you to complete the assessment questionnaire online for this purpose. In addition, if you complete the assessment and posttest online, you can receive continuing education credits as follows. |
||||||||||||||||||||||||||||||||||||
Accrediting Organization |
Credits Offered |
||||||||||||||||||||||||||||||||||||
Accreditation Council for Continuing Medical Education (ACCME) |
The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Centers for Disease Control and Prevention designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
||||||||||||||||||||||||||||||||||||
American Nurses Credentialing Center (ANCC), Commission on Accreditation |
The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1.8 contact hours. |
||||||||||||||||||||||||||||||||||||
National Commission for Health Education Credentialing, Inc. (NCHEC) |
The Centers for Disease Control and Prevention is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is a designated event for the CHES to receive 2.0 Category I contact hours in health education, CDC provider number GA0082. |
||||||||||||||||||||||||||||||||||||
International Association for Continuing Education and Training (IACET) |
The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.2 IACET CEU's for this program. |
||||||||||||||||||||||||||||||||||||
Instructions |
To complete the assessment and posttest, go to Training and Continuing Education Online and follow the instructions on that page. You can immediately print your continuing education certificate from your personal transcript online. No fees are charged. |
||||||||||||||||||||||||||||||||||||
Online Assessment Questionnaire |
1. The learning outcomes (objectives) were relevant to the goal(s) of the course
2. The content was appropriate given the stated objectives of the course
3. The content was presented clearly
4. The learning environment was conducive to learning
5. The delivery method (e.g., web, video, DVD, etc.) helped me learn the material
6. The instructional strategies helped me learn the material.
7. Overall, the quality of the course materials was excellent
8. The difficulty level of the course was
9. Overall, the length of the course was
10. The availability of CE credit influenced my decision to participate in this activity
11. As a result of completing this educational activity, it is likely that I will make changes in my practice
12. I am confident I can better provide appropriate clinical care for patients exposed to environmental hazards as described in this course
13. I intend to apply recommendations from this course in my clinical practice
14. The content expert(s) demonstrated expertise in the subject matter
15. Do you feel this course was commercially biased? If yes, please explain 16. Please describe any technical difficulties you experienced with the course. 17. What could be done to improve future offerings? 18. Do you have any further comments? |
||||||||||||||||||||||||||||||||||||
Posttest |
1. What is arsenic?
2. Most of the arsenic used industrially in recent years in the United States has been for the manufacture of
3. The major route(s) of exposure to arsenic is/are
4. Of the following, the U. S. population most at risk of exposure to arsenic today is
5. Which of the following is FALSE regarding U.S. standards for arsenic levels?
6. After ingestion, most arsenic is
7. Arsenic initiates cellular injury by
8. Of the neurologic effects associated with arsenic exposure, the most common one is
9. Which dermatologic condition(s) may occur from chronic arsenic ingestion?
10. Abnormal laboratory tests in arsenic toxicity include
11. A 64-year-old male who worked in a copper smelter in the United States in the 1960s and 1970s presents complaining of hemoptysis, 30 lb weight loss, and constant chest pain. He says his symptoms began several months ago. Of the arsenic-associated diseases, the MOST LIKELY culprit is
12. As part of the exposure history, you should explore
13. In a patient with an occupational exposure to arsenic several years ago, urinary arsenic is likely to show
14. On peripheral blood smear, basophilic stippling of red cells is suggestive of
15. In caring for a patient who has been exposed to arsenic, it is important to
16. Patients who have been diagnosed with an arsenic-associated disease should be instructed to
|
||||||||||||||||||||||||||||||||||||
Relevant Content |
To review content relevant to the post-test questions, see:
|
Previous Section | Next Section |